Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jochen Klaus Maria Lennerz, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Jochen Lennerz and Lori Wirth.
Connection Strength

0.660
  1. Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma. Thyroid. 2020 09; 30(9):1384-1389.
    View in: PubMed
    Score: 0.225
  2. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma. Oncologist. 2019 10; 24(10):1356-1367.
    View in: PubMed
    Score: 0.207
  3. ROS1 Rearrangement in Thyroid Cancer. Thyroid. 2016 06; 26(6):794-7.
    View in: PubMed
    Score: 0.171
  4. Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer. Ann Oncol. 2020 12; 31(12):1725-1733.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.